Tucson Park Place Covid Clinic

Tucson Park Place Mall Testing Site

5870 East Broadway Blvd., Tucson, AZ 85711
Located in parking lot between Macys and Red Lobster.

This is a drive-through testing location and is located in the parking lot. Patients can stay in the safety of their vehicle. 

 

Patients may be able to receive reimbursement from their health insurance company for all or a portion of their COVID-19 test. Please contact your insurance company for additional information as to whether you may be eligible to receive reimbursement for your COVID-19 test and how to apply. Click Here to see an example of the invoice each patient receives for their test(s).

Tests Available At This Location

Click on a test heading to see additional information

  • $125 Standard Molecular NAAT (PCR or TMA) COVID-19 Test
  • $150 Rapid COVID-19 Antigen Test
  • $299 Rapid COVID-19 Molecular NAAT Test
  • $475 Rapid RT-PCR COVID-19 Test (Best for Travel)

Standard Molecular NAAT (PCR or TMA) COVID-19 Test

Results are generally reported within two to four days

Covid Clinic utilizes multiple independent laboratories to process specimens collected and multiple molecular tests in order to offer PCR or TMA testing on a consistent basis. The molecular NAAT PCR or TMA test will be one of the following three tests, but Covid Clinic is unable to guarantee which of the tests will be utilized for a specific sample:

Roche cobas SARS-CoV-2 RT-PCR

Hologic Aptima SARS-CoV-2 Assay

LabCorp COVID-19 RT PCR Test

Test Information

Covid Clinic is happy to offer COVID-19 PCR or TMA testing services. This testing meets the requirements for most travel restrictions; however, it is the purchaser’s responsibility to review any applicable travel restrictions prior to booking an appointment in order to ensure the service will meet the patient’s travel restriction requirement(s).

The specimen is collected by a nasal (anterior nares) swab. Please note that most travel restrictions require that a traveler’s test specimen IS COLLECTED within 48 to 72 hours upon arrival at destination. Results for the Standard Molecular NAAT (PCR or TMA) COVID-19 Test are generally reported to the patient within two to four days, but this delivery time is not guaranteed. If a patient needs their result delivered with a guaranteed turnaround time please see Covid Clinic’s Expedited Molecular NAAT (PCR or TMA) COVID-19 Test service offering.

Testing specimens collected at Covid Clinic are sent to third-party laboratories for processing. These laboratories may bill the patient’s insurance for their services. Covid Clinic strongly encourages all patients to provide any insurance information so patients may be able to avoid being billed directly by the third-party laboratory that processes the patient’s specimen. If a patient is uninsured, the third-party lab processing the specimen may attempt to collect public funding in lieu of billing the patient.

Rapid COVID-19 Antigen Test

Results are generally reported within 60 minutes at most locations.

Covid Clinic utilizes multiple antigen tests in order to make antigen testing more accessible. The antigen test administered to the patient will be one of the following three tests, but Covid Clinic is unable to guarantee which of the tests will be utilized for a specific patient.

Quidel Corporation Sofia SARS Antigen FIA Test

Access Bio, Inc. CareStart COVID-19 Antigen Test

Luminostics, Inc. Clip COVID Rapid Antigen Test

Test Information

All of Covid Clinic’s antigen test offerings utilize tests that have received emergency use authorization from the FDA.

For Quidel’s Sofia SARS Antigen FIA Test and Luminostics Clip COVID Rapid Antigen Test, the specimen is collected by a nasal swab. The cotton swab does not need to be inserted far into the nose, and is rotated in a circle around the entire inside edge of each nostril at least three times. Results are generally available within 60 minutes and delivered to the patient via email (with the individual’s consent).

For Access Bio’s CareStart COVID-19 Antigen Test, the specimen is collected by a nasopharyngeal swab. Results are generally available within 60 minutes and delivered to the patient via email (with the individual’s consent).

Rapid COVID-19 Molecular NAAT Test

Abbott ID Now COVID-19 Assay

Results are generally reported within 60 minutes at most locations.

Test Information

Covid Clinic, Inc. is offering the Abbott ID Now COVID-19 Assay performed on the ID NOW Instrument. This test is a rapid molecular in vitro diagnostic test utilizing an isothermal nucleic acid amplification technology intended for the qualitative detection of nucleic acid from the SARS-CoV-2 viral RNA in direct nasal swabs. The ID Now COVID-19 Assay has received Emergency Use Authorization (EUA) from the FDA.

Many travel restrictions require a molecular or NAAT test be conducted prior to arrival. Abbott’s ID Now COVID-19 test may satisfy these requirements; however, it is the purchaser’s responsibility to verify the test will be accepted for travel prior to purchase.

The tip of the cotton swab is inserted into both nostrils. The swab does not need to be inserted far, just until the cotton tip of the swab is no longer visible. The swab is then rotated in a circle around the entire inside edge of each nostril at least three times.

Rapid RT-PCR COVID-19 Test

Results are generally reported within two hours

Satisfies most travel restriction requirements

Collected by anterior nares nasal swab (front of the nose only)

Test Information

The Rapid RT-PCR COVID-19 Test is a molecular, in vitro diagnostic test utilizing end point reverse transcriptase polymerase chain reaction (RT-PCR) and lateral flow technologies for the qualitative, visual detection of the coronavirus SARS-CoV-2 viral RNA. The four steps utilized to perform the test are lysis of the virus, reverse transcription of viral RNA to cDNA, nucleic acid amplification, and detection.

The Rapid RT-PCR COVID-19 Test has been released under FDA Emergency Use Authorization (EUA) for the detection of nucleic acid from SARS-CoV-2 (the virus responsible for COVID-19 infection), and can be used in applications that require molecular/ RT-PCR testing. Please consult your state health department for additional information regarding specific uses (such as pre and post travel requirements). Many travel restrictions require a RT-PRC, molecular, or NAAT test be conducted prior to arrival at the destination. The Rapid RT-PCR COVID-19 test satisfies most travel requirements; however, it is the purchaser’s responsibility to verify the test will be accepted for travel prior to purchase.

Standard Molecular NAAT (PCR or TMA) COVID-19 Test

Results are generally reported within two to four days

Covid Clinic utilizes multiple independent laboratories to process specimens collected and multiple molecular tests in order to offer PCR or TMA testing on a consistent basis. The molecular NAAT PCR or TMA test will be one of the following three tests, but Covid Clinic is unable to guarantee which of the tests will be utilized for a specific sample:

Roche cobas SARS-CoV-2 RT-PCR

Hologic Aptima SARS-CoV-2 Assay

LabCorp COVID-19 RT PCR Test

Test Information

Covid Clinic is happy to offer COVID-19 PCR or TMA testing services. This testing meets the requirements for most travel restrictions; however, it is the purchaser’s responsibility to review any applicable travel restrictions prior to booking an appointment in order to ensure the service will meet the patient’s travel restriction requirement(s).

The specimen is collected by a nasal (anterior nares) swab. Please note that most travel restrictions require that a traveler’s test specimen IS COLLECTED within 48 to 72 hours upon arrival at destination. Results for the Standard Molecular NAAT (PCR or TMA) COVID-19 Test are generally reported to the patient within two to four days, but this delivery time is not guaranteed. If a patient needs their result delivered with a guaranteed turnaround time please see Covid Clinic’s Expedited Molecular NAAT (PCR or TMA) COVID-19 Test service offering.

Testing specimens collected at Covid Clinic are sent to third-party laboratories for processing. These laboratories may bill the patient’s insurance for their services. Covid Clinic strongly encourages all patients to provide any insurance information so patients may be able to avoid being billed directly by the third-party laboratory that processes the patient’s specimen. If a patient is uninsured, the third-party lab processing the specimen may attempt to collect public funding in lieu of billing the patient.

Rapid COVID-19 Antigen Test

Results are generally reported within 60 minutes at most locations.

Covid Clinic utilizes multiple antigen tests in order to make antigen testing more accessible. The antigen test administered to the patient will be one of the following three tests, but Covid Clinic is unable to guarantee which of the tests will be utilized for a specific patient.

Quidel Corporation Sofia SARS Antigen FIA Test

Access Bio, Inc. CareStart COVID-19 Antigen Test

Luminostics, Inc. Clip COVID Rapid Antigen Test

Test Information

All of Covid Clinic’s antigen test offerings utilize tests that have received emergency use authorization from the FDA.

For Quidel’s Sofia SARS Antigen FIA Test and Luminostics Clip COVID Rapid Antigen Test, the specimen is collected by a nasal swab. The cotton swab does not need to be inserted far into the nose, and is rotated in a circle around the entire inside edge of each nostril at least three times. Results are generally available within 60 minutes and delivered to the patient via email (with the individual’s consent).

For Access Bio’s CareStart COVID-19 Antigen Test, the specimen is collected by a nasopharyngeal swab. Results are generally available within 60 minutes and delivered to the patient via email (with the individual’s consent).

Rapid COVID-19 Molecular NAAT Test

Abbott ID Now COVID-19 Assay

Results are generally reported within 60 minutes at most locations.

Test Information

Covid Clinic, Inc. is offering the Abbott ID Now COVID-19 Assay performed on the ID NOW Instrument. This test is a rapid molecular in vitro diagnostic test utilizing an isothermal nucleic acid amplification technology intended for the qualitative detection of nucleic acid from the SARS-CoV-2 viral RNA in direct nasal swabs. The ID Now COVID-19 Assay has received Emergency Use Authorization (EUA) from the FDA.

Many travel restrictions require a molecular or NAAT test be conducted prior to arrival. Abbott’s ID Now COVID-19 test may satisfy these requirements; however, it is the purchaser’s responsibility to verify the test will be accepted for travel prior to purchase.

The tip of the cotton swab is inserted into both nostrils. The swab does not need to be inserted far, just until the cotton tip of the swab is no longer visible. The swab is then rotated in a circle around the entire inside edge of each nostril at least three times.

Rapid RT-PCR COVID-19 Test

Results are generally reported within two hours

Satisfies most travel restriction requirements

Collected by anterior nares nasal swab (front of the nose only)

Test Information

The Rapid RT-PCR COVID-19 Test is a molecular, in vitro diagnostic test utilizing end point reverse transcriptase polymerase chain reaction (RT-PCR) and lateral flow technologies for the qualitative, visual detection of the coronavirus SARS-CoV-2 viral RNA. The four steps utilized to perform the test are lysis of the virus, reverse transcription of viral RNA to cDNA, nucleic acid amplification, and detection.

The Rapid RT-PCR COVID-19 Test has been released under FDA Emergency Use Authorization (EUA) for the detection of nucleic acid from SARS-CoV-2 (the virus responsible for COVID-19 infection), and can be used in applications that require molecular/ RT-PCR testing. Please consult your state health department for additional information regarding specific uses (such as pre and post travel requirements). Many travel restrictions require a RT-PRC, molecular, or NAAT test be conducted prior to arrival at the destination. The Rapid RT-PCR COVID-19 test satisfies most travel requirements; however, it is the purchaser’s responsibility to verify the test will be accepted for travel prior to purchase.